ArticleInflammation and regeneration2026

Alveolar type II cell therapy ameliorates pulmonary fibrosis by reprogramming macrophage activation.

Raquel Guillamat-Prats et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.